Beta-alanine as a small molecule neurotransmitter

Area of Science:

• Neuroscience
• Neurochemistry
• Pharmacology

Background:

• Beta-alanine is structurally similar to known amino acid neurotransmitters like glycine and GABA.
• It meets several classical criteria for neurotransmitter function within the central nervous system (CNS).

Purpose of the Study:

• To review the evidence supporting beta-alanine's role as a neurotransmitter.
• To explore its receptor interactions and potential implications for neuropharmacology.

Main Methods:

• Literature review of studies on beta-alanine's presence, release, binding sites, and effects in the CNS.
• Analysis of beta-alanine's interaction with NMDA, glycine, and GABA receptors.
• Examination of its role in glial GABA uptake.

Main Results:

• Beta-alanine is found in the CNS, released via calcium-dependent processes, and binds to multiple receptor sites.
• It interacts with glycine and GABA receptors and influences glial GABA uptake.
• While distinct beta-alaninergic neurons are not identified, its properties suggest a neurotransmitter role.

Conclusions:

• Beta-alanine should be considered a small molecule neurotransmitter alongside other amino acids.
• Its neurochemical properties offer potential for novel drug design.
• Further investigation is needed to fully elucidate its specific neuronal pathways and functions.